Veterinary News,
Explained.

FDA announced approval of the first generic omeprazole oral paste for treatment of gastric ulcers in horses, adding a lower-cost option in an area many owners and equine practices already know well.

FDA approved the first generic injectable robenacoxib for postoperative pain and inflammation associated with certain surgeries in dogs and cats.

FDA added Prazi-Med, a praziquantel immersion powder for ornamental finfish, to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species, creating a legal marketing pathway for a fish-parasite treatment through the indexing system rather than standard approval.

FDA granted full approval to KBroVet for control of seizures associated with idiopathic epilepsy in dogs.

FDA granted full approval to Laverdia, described as the first oral treatment for lymphoma in dogs.

FDA approved the first generic robenacoxib tablets for postoperative pain and inflammation in cats following certain common surgeries.

FDA supplemented approval of Vetmedin to include delaying onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease.

FDA approved the first generic methimazole coated tablets for treating feline hyperthyroidism, expanding access to a common medical therapy for an older-cat endocrine disease.

FDA approved Bravecto Quantum, an extended-release injectable suspension that protects dogs against fleas and ticks for 8 to 12 months, the first FDA-approved long-acting treatment of its kind.

FDA approved the first generic cefovecin sodium injection for treating certain skin infections, abscesses, and wounds in dogs and cats, creating a generic version of Convenia for prescription veterinary use.

FDA added Faunamor to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species, creating a legal treatment option for ich in ornamental pet fish.

FDA conditionally approved Felycin-CA1 (sirolimus delayed-release tablets) for management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy, the first approved product for cats with HCM for any indication.

FDA posted warning letters to six firms selling unapproved products that claimed to treat or control seizures in dogs and cats, emphasizing that seizure care requires veterinary diagnosis, supervision, and legally marketed drugs.